Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Calgizzarin (S100A11) immunost...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
Bibliographic Details
Main Authors:
Rehman, I
,
Azzouzi, A
,
Catto, J
,
Ahmad, M
,
Deloulme, U
,
Cross, S
,
Feeley, K
,
Eaton, C
,
Meuth, M
,
Hamdy, F
Format:
Journal article
Language:
English
Published:
2003
Holdings
Description
Similar Items
Staff View
Similar Items
Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
by: Rehman, I, et al.
Published: (2004)
Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
by: Rehman, I, et al.
Published: (2004)
Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
by: Rehman, I, et al.
Published: (2004)
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
by: Rehman, I, et al.
Published: (2004)
Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.
by: Cross, S, et al.
Published: (2005)